Target intelligence / Profile preview

Peptidyl-prolyl cis-trans isomerase A-like 4A (PPIAL4A)

Target
PPIAL4A
Molecular classification
Enzyme, Peptidyl-prolyl cis-trans isomerase, Cyclophilin family
01

Overview

Peptidyl-prolyl cis-trans isomerase A-like 4A (PPIAL4A) is an enzyme of the cyclophilin family that catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides, accelerating protein folding[1]. PPIAL4A is *predicted* to bind cyclosporin A based on sequence homology and gene family, and localizes to the extracellular exosome[1]. Its precise physiological roles are largely unclear, and its functional characterization in human disease remains limited[1]. While it is a paralog of other cyclophilins and may share general functions such as protein folding (like PPIA), most published functions, disease roles, and mechanisms are attributed to more well-characterized cyclophilins (principally PPIA/cyclophilin A), not directly to PPIAL4A[1][2][6][7]. Disease associations include chromosomal deletion syndromes and some cancers, but it is not currently recognized as a well-validated therapeutic target[1]. The attribution of drug interactions or functional roles to PPIAL4A is largely extrapolated with low confidence, and there is evidence of confusion with aliases for other cyclophilins (e.g., PPIAL4B, PPIA). Therefore, PPIAL4A is considered a predicted member of the cyclophilin PPIase enzyme family, with unvalidated or speculative roles as a distinct therapeutic target in current biomedical literature[1][5][7].

Other names
Peptidyl-prolyl cis-trans isomerase A-like 4APPIAL4ACOAS2PPIAL4BPPIase A-like 4ACOAS-2Chromosome one-amplified sequence 2Cyclophilin homolog overexpressed in liver cancerPPIAL4PPIase A-like 4BPPIase A-like 4G
02

Mechanism of action

Immunosuppression (for cyclosporin A binding cyclophilins, inferred by homology); isomerase inhibition

03

Biological functions

Protein foldingPeptidyl-prolyl cis-trans isomerization
04

Disease associations

Cancer (Well-differentiated liposarcoma, association with liver cancer)Chromosome 1q21.1 deletion syndrome
05

Interacting drugs

Cyclosporin A (predicted binding, based on cyclophilin family)

Beyond the preview

Go deeper on Peptidyl-prolyl cis-trans isomerase A-like 4A (PPIAL4A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidyl-prolyl cis-trans isomerase A-like 4A (PPIAL4A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call